首页 | 本学科首页   官方微博 | 高级检索  
     

LncRNA-MEG3 对胃癌生物学特性及铂类化疗敏感性的研究
引用本文:郭苹,程鹏,王鹏飞,陈小兵. LncRNA-MEG3 对胃癌生物学特性及铂类化疗敏感性的研究[J]. 中国现代医学杂志, 2019, 29(6): 16-21
作者姓名:郭苹  程鹏  王鹏飞  陈小兵
作者单位:(1. 南阳医学高等专科学校第一附属医院 肿瘤内科,河南 南阳 473007 ;2. 河南省肿瘤医院 消化内科,河南 郑州 450022)
摘    要:目的 探讨LncRNA-MEG3 对胃癌增殖、凋亡及顺铂化疗敏感性的影响。方法 以人正常胃黏膜上皮细胞GES1 作为对照细胞,实时荧光定量聚合酶链反应(qRT-PCR)检测胃癌MKN28、SGC7901、AGS 及BGC823 细胞中LncRNA-MEG3 的表达;将过表达MEG3 的质粒转染BGC823 细胞作为pcDNA3.1-MEG3 组,转染空白质粒的阴性对照作为pcDNA3.1 组,同时设置Control 组;将BGC823 细胞分为pcDNA3.1 组、pcDNA3.1-MEG3 组、顺铂组及pcDNA3.1-MEG3+ 顺铂组。qRT-PCR 检测转染48 h后细胞中LncRNA-MEG3 的表达;pcDNA3.1-MEG3、顺铂单独或共同处理BGC823 细胞,细胞计数试剂盒法及流式细胞仪分别检测细胞活力及凋亡率;Western blotting 检测STAT3、磷酸化的信号转导与转录因子3(p-STAT3)、Cyclin D1 和Bcl-2 的表达。结果 胃癌细胞中LncRNA-MEG3 的表达均低于GES1 细胞(P <0.05);4 组LncRNA-MEG3 相对表达量比较,差异有统计学意义(P <0.05);pcDNA3.1-MEG3 组和顺铂组Cyclin D1、Bcl-2 及p-STAT3 的蛋白表达低于pcDNA3.1 组(P <0.05),细胞凋亡率高于pcDNA3.1 组(P <0.05)。结论 胃癌细胞中LncRNA-MEG3 表达降低,过表达LncRNA-MEG3 可降低胃癌细胞活力并诱导细胞凋亡,增加顺铂的化疗敏感性,其机制与下调STAT3 信号通路有关。

关 键 词:胃肿瘤;LncRNA-MEG3 基因/ 基因;细胞凋亡;顺铂
收稿时间:2018-09-22

Effect of LncRNA-MEG3 on proliferation and apoptosis of gastriccancer and chemosensitivity of cisplatin
Ping Guo,Peng Cheng,Peng-fei Wang,Xiao-bing Chen. Effect of LncRNA-MEG3 on proliferation and apoptosis of gastriccancer and chemosensitivity of cisplatin[J]. China Journal of Modern Medicine, 2019, 29(6): 16-21
Authors:Ping Guo  Peng Cheng  Peng-fei Wang  Xiao-bing Chen
Affiliation:(1.Department of Oncology, the First Affiliated Hospital of Nanyang Medical College, Nanyang, Henan473007, China; 2. Department of Gastroenterology, Henan Cancer Hospital,Zhengzhou, Henan 450022, China)
Abstract:Objective To investigate the effect of LncRNA-MEG3 on the proliferation and apoptosis ofgastric cancer and the chemosensitivity of cisplatin. Methods Using human normal gastric epithelial cell GES1as control cells, the expressions of LncRNA-MEG3 in MKN28, SGC7901, AGS and BGC823 gastric cancer cellswere detected by qRT-PCR; the plasmid that overexpressed MEG3 was transfected into BGC823 cells (pcDNA3.1-MEG3 group), and blank plasmid was added as negative control (pcDNA3.1 group), and blank control group wasset up, and the expression of LncRNA-MEG3 was detected by qRT-PCR cells transfected with 48h; BGC823 cellswere treated by pcDNA3.1-MEG3 and cisplatin alone or together, and CCK8 assay and flow cytometry were used to detect cell viability and apoptosis rate; the expression of STAT3, p-STAT3Cyclin D1 and Bcl-2 protein were detected by western blotting. Results The expression of LncRNA-MEG3 in gastric cancer cells was lower than that in GES1 cells (P < 0.05); the relative expression of LncRNA-MEG3 in four groups was significantly different (P < 0.05); the expressions of Cyclin D1, Bcl-2 and p-STAT3 protein were significantly lower in pcDNA3.1-MEG3 group and cisplatin group than those in pcDNA3.1 group, but apoptosis rate was significantly higher (P < 0.05). Conclusions The expression of LncRNA-MEG3 decreases in gastric cancer cells. Overexpression of LncRNA-MEG3 can reduce gastric cancer cell viability and induce cell apoptosis, and increase the chemosensitivity of cisplatin, which is related to downregulation of STAT3 signaling pathway.
Keywords:stomach neoplasms   LncRNA-MEG3/ genes   apoptosis   cisplatin
点击此处可从《中国现代医学杂志》浏览原始摘要信息
点击此处可从《中国现代医学杂志》下载全文
设为首页 | 免责声明 | 关于勤云 | 加入收藏

Copyright©北京勤云科技发展有限公司  京ICP备09084417号